Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Dead fish in Hyderabad puts pharma majors under scrutiny; False data uncovered in AstraZeneca’s US$ 4 billion buy
This week, Phispers has news from across the world. While China is trying to speed up approval of dr
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan
This week, Phispers brings you the latest from the world of biosimilars, with Samsung Bioepis tying
Dr. Reddy’s fails EU inspection; Trump disbands business councils after Merck CEO and others quit it over intolerance
This week, Phispers brings you the high-pitched drama from President Trump’s American Manufact
GSK’s overhaul begins under new CEO; Sandoz loses US$ 940 million lawsuit
This week, Phispers brings you news on GSK, whose new CEO is planning a slew of initiatives to make
FDA problems at Pfizer’s US facility continue; China FDA joins ICH
This week in our compliance round up, we look at the continuing problems at Pfizer’s McPherson
Does the FDA promote European manufacturers over others? The ice-bucket challenge winner!
This
week, Phispers brings you a short analysis on how FDA might be promoting
European drugmakers ov
Pfizer’s US facility receives a warning letter, as Baxter’s cGMP deficiencies result in multi-million dollar legal settlement
Within two
months of 2017, we have already seen several pharmaceutical companies come
under the regu
Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China
This week, Phispers highlights more bad news for Israeli drugmaker Teva, along with news on the &lsq
China shuts plants of major antibiotic producers to fight pollution; more troubles for Teva
This week, Phispers has lots on generics. While the global leader Teva has more troubles at hand, ge
